Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 2015-09-01 (10 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PLOERMEL (56800), Morbihan
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DU LAC : revenue, balance sheet and financial ratios
PHARMACIE DU LAC is a French company
founded 10 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PLOERMEL (56800),
this company of category PME
shows in 2022 a revenue of 4.4 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU LAC (SIREN 813496239)
Indicator
2025
2024
2022
2018
2017
2016
Revenue
N/C
N/C
4 385 698 €
N/C
N/C
N/C
Net income
356 422 €
236 445 €
148 460 €
110 087 €
109 294 €
-31 130 €
EBITDA
N/C
N/C
208 195 €
N/C
N/C
N/C
Net margin
N/C
N/C
3.4%
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE DU LAC generates positive net income of 356 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
356 422 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 90%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 44%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
89.788%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
43.949%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2022
2024
2025
Debt ratio
183.515
143.913
122.668
155.233
138.782
89.788
Financial autonomy
27.841
33.029
37.763
31.473
34.906
43.949
Repayment capacity
None
None
None
10.369
None
None
Cash flow / Revenue
None%
None%
None%
3.392%
None%
None%
Sector positioning
Debt ratio
89.792025
2022
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average-6 pts over 3 years
In 2025, the debt ratio of PHARMACIE DU LAC (89.79) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
43.95%2025
2022
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Average+9 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DU LAC (44.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
10.37 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of PHARMACIE DU LAC (10.37) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 129.21. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
129.207
Liquidity indicators evolution PHARMACIE DU LAC
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2022
2024
2025
Liquidity ratio
72.342
67.962
55.367
100.298
112.202
129.207
Interest coverage
None
None
None
8.098
None
None
Sector positioning
Liquidity ratio
129.212025
2022
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Watch+7 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DU LAC (129.21) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
8.1x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Excellent
In 2022, the interest coverage of PHARMACIE DU LAC (8.1x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DU LAC
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2022
2024
2025
Operating WCR
0 €
0 €
0 €
328 401 €
0 €
0 €
Inventory turnover (days)
0
0
0
31
0
0
Customer payment term (days)
0
0
0
4
0
0
Supplier payment term (days)
0
0
0
51
0
0
Positioning of PHARMACIE DU LAC in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DU LAC is estimated at
5 661 805 €
(range 3 842 128€ - 8 884 153€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
3842k€5661k€8884k€
5 661 805 €Range: 3 842 128€ - 8 884 153€
NAF 5 année 2025
Valuation method used
Net Income Multiple
356 422 €
×
15.9x
=5 661 806 €
Range: 3 842 128€ - 8 884 153€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU LAC with other companies in the same sector:
The revenue of PHARMACIE DU LAC in 2022 is 4.4 M€.
Is PHARMACIE DU LAC profitable?
Yes, PHARMACIE DU LAC generated a net profit of 356 k€ in 2025.
Where is the headquarters of PHARMACIE DU LAC ?
The headquarters of PHARMACIE DU LAC is located in PLOERMEL (56800), in the department Morbihan.
Where to find the tax return of PHARMACIE DU LAC ?
The tax return of PHARMACIE DU LAC is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU LAC operate?
PHARMACIE DU LAC operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart